比较1.8 mL与3.6 mL麻醉液下牙槽神经阻滞对不可逆性牙髓炎患牙的麻醉效果:系统评价与Meta分析及试验序贯分析
该系统评价与Meta分析纳入4项随机临床试验共280颗牙,比较1.8 mL与3.6 mL同种麻醉液行下牙槽神经阻滞对不可逆性牙髓炎下颌牙的麻醉成功率。结果显示3.6 mL组成功率显著更高(RR=1.94;95%CI 1.07,3.52;I2=77%),试验序贯分析证实结论确定,GRADE证据质量评为高。
要点
- 3.6 mL麻醉液行下牙槽神经阻滞的成功率显著高于1.8 mL(RR=1.94;95%CI 1.07,3.52)。
- 试验序贯分析确认3.6 mL获益证据为「确定性」,GRADE证据质量评为「高」。
- 证据仅来自4项随机临床试验共280颗下颌牙,年龄18至65岁。
核心结论
- 将麻醉液容量从1.8 mL增至3.6 mL可提高不可逆性牙髓炎下颌磨牙下牙槽神经阻滞的成功率。
- 该结论的证据质量评为「高」。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Scopus和EBSCOhost数据库至2020年5月。
- 纳入4项英文随机临床试验,共280颗牙,患者年龄18至65岁。
- 采用随机效应模型进行Meta分析,并用试验序贯分析评估随机误差的影响。
- 使用修订版Cochrane偏倚风险工具评估偏倚风险,GRADE方法评价证据质量。
主要发现
- 4项试验中3项偏倚风险为「低」,1项为「有一些担忧」。
- 主Meta分析显示3.6 mL组下牙槽神经阻滞成功率显著高于1.8 mL组(RR=1.94;95%CI 1.07,3.52;I2=77%)。
- 仅纳入使用Heft-Parker视觉模拟疼痛量表的试验进行敏感性分析,同样显示3.6 mL显著提高成功率。
- 试验序贯分析确认3.6 mL获益证据为「确定性」。
关键数值与推荐
- 3.6 mL与1.8 mL同种麻醉液行下牙槽神经阻滞的成功率比较:RR=1.94;95%CI 1.07,3.52;I2=77%。
- 证据质量GRADE分级为「高」。
临床怎么用
- 对不可逆性牙髓炎下颌磨牙行下牙槽神经阻滞时,可考虑使用3.6 mL而非1.8 mL同种麻醉液以提高成功率。
- 临床决策需结合具体麻醉液类型和患牙类型,因现有证据仅基于特定条件。
局限性
- 仅纳入4项随机临床试验共280颗牙,样本量有限。
- Meta分析异质性较高(I2=77%)。
- 证据仅涉及特定麻醉液和下颌磨牙,未来需不同麻醉液类型和其他牙类型的高质量临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The scientific literature is contradictory in relation to selecting the appropriate volume of local anaesthetic solution for inferior alveolar nerve blocks (IANB) when attempting to anaesthetize mandibular teeth with irreversible pulpitis. OBJECTIVES: To compare the efficacy of 1.8 and 3.6 mL of the same anaesthetic solution for IANBs when treating mandibular teeth with irreversible pulpitis. METHODS: A literature search was performed in PubMed, Scopus and EBSCOhost databases until May 2020. Randomized clinical trials published in English, comparing 1.8 with 3.6 mL of the same anaesthetic solution for IANBs in permanent mandibular teeth with irreversible pulpitis, were included. The risk of bias of the included trials was appraised using the revised Cochrane risk of bias tool. A meta-analysis was performed using the random-effects model. The effect of random errors on the results of the meta-analysis was evaluated by trial sequential analysis and the quality of evidence was appraised using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. RESULTS: Four clinical trials involving 280 teeth from patients with ages ranging from 18 to 65 years were included. Among the four trials, three were categorized as having a 'low' risk of bias and one was categorized as having 'some concerns'. The primary meta-analysis revealed that 3.6 mL of anaesthetic solution when administered for IANBs was associated with significantly greater success rates compared with 1.8 mL (RR = 1.94; 95% CI, 1.07, 3.52; I2 = 77%). Similarly, the results of the sensitivity analysis (restricting trials only to those that used the Heft-Parker visual analogue pain scale) revealed that the use of 3.6 mL significantly increased the success of IANBs compared with 1.8 mL. The trial sequential analysis confirmed the evidence for the beneficial effect of 3.6 mL to achieve success for IANBs was 'conclusive'. The quality of evidence was graded as 'high'. CONCLUSION: Increasing the volume of anaesthetic solution from 1.8 to 3.6 mL improved the success rate for IANBs in mandibular molars with irreversible pulpitis. The quality of the evidence was 'high'. Future high-quality clinical trials are required with different types of anaesthetic solutions and other types of teeth.
引用
- Nagendrababu V, Abbott PV, Pulikkotil SJ, et al. Comparing the anaesthetic efficacy of 1.8 mL and 3.6 mL of anaesthetic solution for inferior alveolar nerve blocks for teeth with irreversible pulpitis: a systematic review and meta-analysis with trial sequential analysis. Int Endod J. 2020. PMID: 33040335. doi:10.1111/iej.13428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。